JFLLIFE — JFL Life Sciences Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- IN₹590.62m
- IN₹758.76m
- IN₹327.75m
2019 March 31st | 2020 March 31st | 2021 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 318 | 302 | 328 |
Cost of Revenue | |||
Gross Profit | 26.5 | 37.2 | 38.6 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Other Operating Expenses | |||
Total Operating Expenses | 306 | 285 | 309 |
Operating Profit | 11.7 | 16.3 | 18.9 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 4.23 | 4.97 | 7.47 |
Provision for Income Taxes | |||
Net Income After Taxes | 3.02 | 3.6 | 5.42 |
Net Income Before Extraordinary Items | |||
Net Income | 3.02 | 3.6 | 5.42 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 3.02 | 3.6 | 5.42 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 0.275 | 0.328 | 0.493 |
Dividends per Share |